In today’s session DENTSPLY SIRONA Inc (XRAY) recorded an unusually high (1,524) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the December, 2016 put, expecting serious XRAY decrease. With 1,524 contracts traded and 1114 open interest for the Dec, 16 contract, it seems this is a quite bearish bet. The option with symbol: XRAY161216P00060000 closed last at: $1.6 or 5.9% down. The stock increased 1.10% or $0.66 on November 23, hitting $60.51. About 1.35M shares traded hands. DENTSPLY SIRONA Inc (NASDAQ:XRAY) has declined 0.35% since April 22, 2016 and is downtrending. It has underperformed by 5.76% the S&P500.
Analysts await DENTSPLY SIRONA Inc (NASDAQ:XRAY) to report earnings on February, 10. They expect $0.67 EPS, up 3.08% or $0.02 from last year’s $0.65 per share. XRAY’s profit will be $154.57M for 22.58 P/E if the $0.67 EPS becomes a reality. After $0.66 actual EPS reported by DENTSPLY SIRONA Inc for the previous quarter, Wall Street now forecasts 1.52% EPS growth.
DENTSPLY SIRONA Inc (NASDAQ:XRAY) Ratings Coverage
Out of 12 analysts covering Dentsply International (NASDAQ:XRAY), 8 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 67% are positive. Dentsply International has been the topic of 18 analyst reports since August 3, 2015 according to StockzIntelligence Inc. The stock has “Neutral” rating given by UBS on Thursday, February 25. The stock of DENTSPLY SIRONA Inc (NASDAQ:XRAY) earned “Hold” rating by Zacks on Thursday, September 3. The firm earned “Neutral” rating on Thursday, September 22 by JP Morgan. The company was upgraded on Wednesday, September 16 by Robert W. Baird. Zacks upgraded it to “Hold” rating and $64 target price in Wednesday, August 19 report. Morgan Stanley downgraded DENTSPLY SIRONA Inc (NASDAQ:XRAY) rating on Thursday, March 24. Morgan Stanley has “Equal-Weight” rating and $65 price target. Northcoast upgraded DENTSPLY SIRONA Inc (NASDAQ:XRAY) on Friday, September 18 to “Buy” rating. Bank of America maintained DENTSPLY SIRONA Inc (NASDAQ:XRAY) on Wednesday, September 16 with “Buy” rating. The stock of DENTSPLY SIRONA Inc (NASDAQ:XRAY) earned “Overweight” rating by Morgan Stanley on Tuesday, November 1. The stock of DENTSPLY SIRONA Inc (NASDAQ:XRAY) has “Outperform” rating given on Monday, September 21 by Northcoast.
According to Zacks Investment Research, “DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company’s products include dental prosthetics, endodontic instruments, dental sealants, ultrasonic scalers, dental x-ray equipment and intraoral cameras. DENTSPLY SIRONA Inc., formerly known as DENTSPLY International Inc., is based in United States.”
Insitutional Activity: The institutional sentiment increased to 0.45 in Q2 2016. Its up 0.19, from 0.26 in 2016Q1. The ratio improved, as 12 funds sold all DENTSPLY SIRONA Inc shares owned while 7 reduced positions. 3 funds bought stakes while 2 increased positions. They now own 2.10 million shares or 26.85% less from 2.88 million shares in 2016Q1.
Buffington Mohr Mcneal accumulated 0.22% or 8,025 shares. West Oak Ltd Liability holds 21,540 shares or 0% of its portfolio. Wendell David Assocs has 28,567 shares for 0.35% of their US portfolio. Lmr Partners Llp holds 0.13% or 13,795 shares in its portfolio. Df Dent And Com Inc holds 4,300 shares or 0.01% of its portfolio. De Burlo Gru Inc has 1.98% invested in the company for 132,050 shares. Alleghany Corp De, a New York-based fund reported 1.60M shares. Gemmer Asset Ltd Limited Liability Company owns 237 shares or 0.01% of their US portfolio. Cardinal Management holds 1.69% or 67,070 shares in its portfolio. Palo Capital has 40,422 shares for 0.86% of their US portfolio. Westport Resources Mgmt accumulated 7,300 shares or 0.15% of the stock. Fortaleza Asset has 73 shares for 0% of their US portfolio. The New York-based Tirschwell & Loewy Inc has invested 1.67% in DENTSPLY SIRONA Inc (NASDAQ:XRAY). Liberty Cap Management holds 0.57% of its portfolio in DENTSPLY SIRONA Inc (NASDAQ:XRAY) for 13,550 shares. Huntington Natl Bank holds 5,950 shares or 0.01% of its portfolio.
Insider Transactions: Since May 25, 2016, the stock had 0 buys, and 5 insider sales for $7.84 million net activity. On Tuesday, September 6 Berthan Rainer sold $305,597 worth of the stock or 5,000 shares. $3.61 million worth of DENTSPLY SIRONA Inc (NASDAQ:XRAY) was sold by CLARK CHRISTOPHER T on Tuesday, November 8. Another trade for 2,091 shares valued at $127,159 was made by ALFANO MICHAEL C on Tuesday, November 8. Shares for $2.73 million were sold by MacInnis Maureen J. on Thursday, August 25.
DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, makes and markets a range of consumable dental products for the professional dental market. The company has a market cap of $13.96 billion. The Firm also makes and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. It has a 31.07 P/E ratio. The Company’s divisions include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses.
XRAY Company Profile
DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., incorporated on February 15, 1983, designs, develops, makes and markets a range of consumable dental products for the professional dental market. The Firm also makes and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s divisions include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Firm distributes its products in over 120 countries.
More recent DENTSPLY SIRONA Inc (NASDAQ:XRAY) news were published by: Wsj.com which released: “Dentsply Sirona to Buy MIS Implants for $375 Million” on June 27, 2016. Also Seekingalpha.com published the news titled: “Dentsply Sirona’s (XRAY) CEO Jeffrey Slovin on Q2 2016 Results – Earnings Call …” on August 05, 2016. Nasdaq.com‘s news article titled: “DENTSPLY SIRONA is Now Oversold (XRAY)” with publication date: October 26, 2016 was also an interesting one.